30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

ConforMIS iTotal CR Survivorship: 4-Year Data -

Summary data from the U.K.'s National Joint Registry indicates that patients treated with the Conformis iTotal CR knee experienced a cumulative revision rate of 0.5% at four years vs. a 1.9% cumulative revision rate at four years, among all patients who underwent knee replacement. The data summarized 576 iTotal procedures in 504 patients from 46 centers in the U.K. (ConforMIS, Inc., 3/7/18)